Bifonazole is an antifungal drug intended for external use.
Release form and composition
Produce several dosage forms Bifonazola:
- Cream and ointment 1% in cans or tubes of 30 g;
- Powder 1% in banks of 30 g;
- A solution of 1% in vials of 15 ml.
The active component of all dosage forms of the drug is bifonazole.
Indications for use
According to the instructions, Bifonazole is indicated for the treatment of:
- Candidiasis of the genitals;
- Mycosis of the hands and feet;
- Multi-colored lichen;
- Hyperhidrosis of the feet;
- Interdigital diaper rash;
- Trichophytosis (both smooth skin areas and scalp);
- Candida nails and nail rollers;
- Groin athlete's foot;
- Superficial candidiasis of the skin.
According to the instructions, Bifonazole is not prescribed for hypersensitivity to the active component of the drug, as well as lanolin and cetylstearol.
In the application Bifonazola caution should be exercised during pregnancy (especially in the first trimester). Bifonazole is also prescribed to young children with caution and under close medical supervision.
Dosing and Administration
Cream, ointment and solution Bifonazol is used for lesions on the smooth surface of the skin. The drug is applied in a thin layer to the affected areas once a day, preferably at bedtime.
As a rule, for treating a damaged surface the size of a palm is 0.5-1 cm of a strip of ointment or cream, or 3 drops of a solution.
It is recommended to use different forms of the drug in the following sequence: first, the solution - until the inflammation subsides, then an ointment or cream, and only last of all - powder.
When treating mycosis of the scalp, it is recommended to use only Bifonazole solution (it is advisable to apply the medicine to the shaved area of the skin). For hyperhidrosis, it is advisable to use only Bifonazole powder.
The duration of therapy varies depending on the type of pathogen, the size of the lesion and the location of the infection. As a rule, the duration of treatment is:
- With mycoses of the body, hands, skin folds, hyperhidrosis of the feet - 2-3 weeks;
- With erythrasma - 2 weeks;
- With mycoses of the feet and interdigital areas - 3 weeks;
- With superficial candidiasis of the skin - 2-4 weeks;
- With mycosis of the scalp - at least 1 month.
After the disappearance of the symptoms of the disease, it is advisable to continue the use of Bifonazole for another 1-2 weeks to prevent recurrence.
When onychomycosis apply cream and ointment Bifonazol. A thin layer of the drug is applied to the affected surfaces using a dosed device, after which the treated areas are covered with a plaster (included in the kit) and left for a day. The next day, hands or feet are immersed in warm water for 10 minutes and using a scraper (included) to remove the infected tissue of the nail plate. After that, the nails should be dried, again apply the tool and cover with a plaster.
Thus, treatment should continue until the entire affected part of the nail is eliminated. It usually takes 1-2 weeks. After that, some more time, apply the powder and the solution Bifonazol.
Application Bifonazola mainly positively tolerated by patients. Occasionally possible:
- Contact dermatitis;
- Burning sensation at the site of application.
For small nails, the patch that comes with the medicine should be divided in half. Do not reapply the patch. If the patches attached to the medication are not enough for the period of therapy, you can replace them with an ordinary waterproof patch, pre-cutting them to suitable sizes.
Ointment and cream Bifonazol act only on the affected areas of the nail, however, it is possible the occurrence of irritation on the skin. If irritating reactions occur, zinc paste can be used.
If the use of Bifonazol does not have the desired therapeutic effect, it should be reported to your doctor, who will prescribe an additional examination to the patient (diagnosis of the endocrine system and immune status, blood test). After receiving the results, your doctor will correct the treatment regimen.
Self-treatment with Bifonazole is prohibited, especially for women in the first trimester of pregnancy. During this period, the feasibility of using the drug can only be determined by the attending physician, comparing the possible risks to the fetus and the benefits to the mother.
Structural analogues of Bifonazole are:
Terms and conditions of storage
According to the instructions, Bifonazole should be stored in a dry, dark and out of reach of children. The shelf life of all dosage forms is 2 years.